A 2021 review of 35 studies (1,964 participants) reaffirmed the conclusion from a 2015 review that if there is an effect, it may be too small to be meaningful
Access occurs primarily through: Clinical trial participation The most appropriate route for most individuals Research institutions For qualified scientific investigation Compounding pharmacies Limited availability with quality and purity concerns Research peptide suppliers For laboratory research only, not human consumption Research-grade peptides serve legitimate scientific purposes but require appropriate handling, storage, and application within proper research contexts
The peptide's pharmacokinetics in dogs absorption, half-life, and clearance have not been characterized, so neither dosing frequency nor the ideal timing of administration relative to an injury is known
Suitability depends on the peptide's stability and health goals, with peptides like Desmopressin being established examples
Acknowledgments We would like to thank Nicola Ryan, who edited a preliminary draft of this manuscript on behalf of Springer Healthcare Communications
